Home » Pending Litigation to Delay Launch of Generic Asacol
Pending Litigation to Delay Launch of Generic Asacol
March 30, 2010
Boehringer Ingelheim’s Roxane Laboratories will postpone until at least November planned sales of its generic version of Asacol, an ulcerative colitis
drug, to resolve a patent infringement suit over the drug.